Table 3.

IL-1β levels in serum of infected mice after different treatment (ng/ml).

Treatment	0 h	2 h	4 h	6 h
Blank control	284.71 ± 0.44	283.22 ± 0.88	284.58 ± 0.35	285.02 ± 0.78
Negative control	284.77 ± 0.22	298.45 ± 0.62#	396.24 ± 0.19#	334.73 ± 0.36#
Cefoperazone/sulbactam	285.09 ± 0.34	297.84 ± 0.52#	353.26 ± 0.75*,#	296.89 ± 0.52*,#
Dexamethasome	285.66 ± 0.32	318.05 ± 0.08*,#	377.00 ± 0.23*,#	289.62 ± 0.13*
B-IgY	284.17 ± 0.40	300.50 ± 0.16*,#	322.34 ± 0.50*,#	285.04 ± 0.69*
C-IgY	285.33 ± 0.22	284.81 ± 0.38*	289.03 ± 0.34*	284.88 ± 0.11*

Data are presented as means ± SD (n = 3).

^#p < 0.05 compared with the blank control at the same time.

^*p < 0.05 compared with the negative control at the same time.